These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 12606295

  • 1. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
    Bauter MR, Brockel BJ, Pankevich DE, Virgolini MB, Cory-Slechta DA.
    Neurotoxicology; 2003 Mar; 24(2):227-43. PubMed ID: 12606295
    [Abstract] [Full Text] [Related]

  • 2. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
    Cory-Slechta DA, O'Mara DJ, Brockel BJ.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):794-805. PubMed ID: 9694936
    [Abstract] [Full Text] [Related]

  • 3. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.
    Haberny SL, Carr KD.
    Neuroscience; 2005 Aug; 132(4):1035-43. PubMed ID: 15857708
    [Abstract] [Full Text] [Related]

  • 4. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release.
    Peleg-Raibstein D, Feldon J.
    Neuropharmacology; 2006 Oct; 51(5):947-57. PubMed ID: 16876207
    [Abstract] [Full Text] [Related]

  • 5. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S.
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [Abstract] [Full Text] [Related]

  • 6. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
    Gilbert ME, Lasley SM.
    Neurotoxicol Teratol; 2007 Nov; 29(3):385-93. PubMed ID: 17350801
    [Abstract] [Full Text] [Related]

  • 7. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
    Tan SE.
    Brain Res Bull; 2008 Dec 16; 77(6):412-9. PubMed ID: 18929625
    [Abstract] [Full Text] [Related]

  • 8. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR, Liljequist S.
    J Pharmacol Exp Ther; 2004 Nov 16; 311(2):560-7. PubMed ID: 15256539
    [Abstract] [Full Text] [Related]

  • 9. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study.
    Hong SK, Jung IS, Bang SA, Kim SE.
    Neurosci Lett; 2006 Dec 06; 409(3):220-3. PubMed ID: 17046158
    [Abstract] [Full Text] [Related]

  • 10. Sensitization to amphetamine occurs simultaneously at immune level and in met-enkephalin of the nucleus accumbens and spleen: an involved NMDA glutamatergic mechanism.
    Assis MA, Hansen C, Lux-Lantos V, Cancela LM.
    Brain Behav Immun; 2009 May 06; 23(4):464-73. PubMed ID: 19486656
    [Abstract] [Full Text] [Related]

  • 11. Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity.
    Cory-Slechta DA.
    Neurotoxicology; 1997 May 06; 18(3):673-88. PubMed ID: 9339816
    [Abstract] [Full Text] [Related]

  • 12. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K, Takahashi I, Watanabe S, Aono Y, Ikeda H, Saigusa T, Nagase H, Suzuki T, Koshikawa N, Cools AR.
    Neuroscience; 2005 May 06; 130(3):745-55. PubMed ID: 15590157
    [Abstract] [Full Text] [Related]

  • 13. Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats.
    Filip M, Papla I, Nowak E, Jungersmith K, Przegaliński E.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep 06; 366(3):226-34. PubMed ID: 12172705
    [Abstract] [Full Text] [Related]

  • 14. Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats.
    Murray F, Harrison NJ, Grimwood S, Bristow LJ, Hutson PH.
    Eur J Pharmacol; 2007 May 21; 562(3):191-7. PubMed ID: 17321516
    [Abstract] [Full Text] [Related]

  • 15. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment.
    Zuch CL, O'Mara DJ, Cory-Slechta DA.
    Toxicol Appl Pharmacol; 1998 May 21; 150(1):174-85. PubMed ID: 9630467
    [Abstract] [Full Text] [Related]

  • 16. Learning versus performance impairments following regional administration of MK-801 into nucleus accumbens and dorsomedial striatum.
    Cory-Slechta DA, O'Mara DJ, Brockel BJ.
    Behav Brain Res; 1999 Jul 21; 102(1-2):181-94. PubMed ID: 10403026
    [Abstract] [Full Text] [Related]

  • 17. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O, Piras G, Lecca D, Corda MG.
    Neuroscience; 2005 Jul 21; 135(3):987-98. PubMed ID: 16154292
    [Abstract] [Full Text] [Related]

  • 18. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
    Leonetti M, Desvignes C, Bougault I, Souilhac J, Oury-Donat F, Steinberg R.
    Neuroscience; 2006 Jul 21; 137(2):555-64. PubMed ID: 16289893
    [Abstract] [Full Text] [Related]

  • 19. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.
    Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2010 Apr 14; 166(4):1056-67. PubMed ID: 20096336
    [Abstract] [Full Text] [Related]

  • 20. Different function of pedunculopontine GABA and glutamate receptors in nucleus accumbens dopamine, pedunculopontine glutamate and operant discriminative behavior.
    Steiniger-Brach B, Kretschmer BD.
    Eur J Neurosci; 2005 Oct 14; 22(7):1720-30. PubMed ID: 16197512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.